3.31
-0.31(-8.56%)
Currency In USD
| Previous Close | 3.62 |
| Open | 3.6 |
| Day High | 3.6 |
| Day Low | 3.28 |
| 52-Week High | 236.79 |
| 52-Week Low | 3.28 |
| Volume | 175,789 |
| Average Volume | 863,483 |
| Market Cap | 1.93M |
| PE | 0 |
| EPS | -2,258.79 |
| Moving Average 50 Days | 5.45 |
| Moving Average 200 Days | 6.95 |
| Change | -0.31 |
If you invested $1000 in Aclarion, Inc. (ACON) since IPO date, it would be worth $0.01 as of January 31, 2026 at a share price of $3.31. Whereas If you bought $1000 worth of Aclarion, Inc. (ACON) shares 3 years ago, it would be worth $0.04 as of January 31, 2026 at a share price of $3.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028
GlobeNewswire Inc.
Jan 13, 2026 11:00 AM GMT
Debt-Free Balance Sheet With $21.6 Million in CashBROOMFIELD, Colo., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarke
Aclarion Provides 2025 Update and 2026 Corporate Outlook
GlobeNewswire Inc.
Jan 08, 2026 11:00 AM GMT
Quarterly Nociscan scan volumes increased 114% year-over-year in Q4 2025Annual Nociscan scan volumes increased 69% year-over-year in 2025Debt-free balance sheet with $12.0 million in cash as of December 31, 2025, extending cash runway into 2027 and p
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
GlobeNewswire Inc.
Jan 06, 2026 11:00 AM GMT
Northwestern and Scripps Health join two previously announced sites in achieving this critical patient enrollment milestone Seven leading U.S. spine centers have now completed the regulatory and operational requirements to screen and enroll patients